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Abstract
Sub-Saharan Africa is currently undergoing an epidemiological transition from a disease burden largely attribu-
table to communicable diseases to that resulting from a combination of both communicable and chronic non-com-
municable diseases. Data on chronic disease incidence, lifestyle, environmental and genetic risk factors are sparse in
this region. This report aimed at providing relevant information in respect to risk factors that increase blood pressure
and lead to development of intermediate cardiovascular phenotypes. We presented the rationale, objectives and key
methodological features of the Nigerian Population Research on Environment, Gene and Health (NIPREGH) study.
The challenges encountered in carrying out population study in this part of the world and the approaches at sur-
mounting them were also presented. The preliminary data as at 20 November 2013 showed that out of the 205 indi-
viduals invited starting from early April 2013, 160 (72 women) consented and were enrolled; giving a response rate
of 78%. Participants9 age ranged from 18 to 80 years, with a mean (SD) of 39.8 (12.4) years and they were of 34
different ethnic groups spread over 24 states out of the 36 states that constitute Nigeria. The mean (SD) of office and
home blood pressures were 113.0 (15.2) mm Hg systolic, 73.5 (12.5) mm Hg diastolic and 117.3 (15.0) mm Hg
systolic, and 76.0 (9.6) mm Hg diastolic, respectively. Forty-three (26.8%) participants were hypertensive and 8
(5.0%) were diabetic. In addition to having the unique potential of recruiting a cohort that is a true representative
of the entire Nigerian population, NIPREGH is feasible and the objectives realisable.
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INTRODUCTION
Cardiovascular diseases (CVDs) have become a
major public health challenge in low and middle
income countries
[1-5]
. It is currently estimated that
80% of global deaths due to CVDs occur in these
countries with most deaths and disabilities occurring
in people at the most productive stage of their life, thus
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resulting in huge negative economic impact on the
society
[6]
. High blood pressure is the main driver of
CVDs and is a major risk factor for stroke, ischaemic
heart and kidney diseases
[7,8]
A key element necessary for developing an effective
prevention and control strategy for CVDs in Nigeria is
availability of country specific risk factor burden.
Previous studies
[2]
were restricted to smaller regions of
the country, involved participants from one ethnic group
and made use of non-standardised protocol that makes
comparison across studies impossible. Additionally,
studies targeted at understanding the genetic basis of
distinct characteristics of hypertension and other
CVDs among Black people are rare. We therefore
mounted the Nigerian Population Research on
Environment, Gene and Health (NIPREGH) study with
the following objectives: (i) to determine the association
of lifestyle and environmental factors with different
blood pressure and other intermediate cardiovascular
phenotypes; (ii) to determine the common polymorph-
ism associated with different blood pressure and other
intermediate cardiovascular phenotypes in Nigeria; (iii)
to evaluate possible gene-environment interaction of
some environmental factors and identified genotypes;
(iv) to generate the genetic material needed to join the
international consortium.
SUBJECTS AND METHOD
Study site
Participants were recruited from the Federal Housing
Authority Estate, Lugbe, Federal Capital Territory
Abuja. Abuja is a new city, carved out in 1976 within
the central region of Nigeria to serve as the new capital
city of the country. It is located between latitude 8.25u
and 9.20u north and longitude 6.45u and 7.39u east.
The topography is majorly of highlands between 600
to 1,000 meters above sea level. Its climate is typically
tropical and year round temperatures oscillate between
25uC to 38uC.
The population of Abuja has grown steadily from
about 170,000 in 1991 to a current estimate of 1.4 mil-
lion. This population growth is occasioned by the offi-
cial movement of the seat of government from Lagos to
Abuja in 1995. Inhabitants of the city are from different
ethnic groups within Nigeria who have migrated from
their ancestral homes. The study site, Federal Housing
Authority Estate, Lugbe has about 4,200 housing units
inhabited by about 16,800 middle income earners.
General design/recruitment
NIPREGH is a prospective cohort study that will
recruit about 1,200 Nigerians, 18 years and above,
and residing within the Federal Housing Authority
Estate Lugbe, Abuja. Prior to actual recruitment, a
community mobilisation through the churches and
mosques within the housing estate is carried out.
Billboards containing messages explaining the place
of health survey in informing health policies as well
as the accruing benefits of the health survey to partici-
pants are placed at a strategic position of a street to be
visited 1 week before the street was visited by trained
field workers. Individual homes within the streets are
visited on Saturdays and Sundays when the majority
of the residents are expected to be available at home.
Field workers visit each house (First home visit)
within a street and inhabitants who are willing to par-
ticipate will have their blood pressure measured after
signing an informed consent. Thereafter, they are
invited to the field centre which is located within
1 km radius of all houses in the estate for other exam-
inations as detailed in Table 1. The visit to the field
centre should take place within 2 weeks of first home
visit. A second home visit takes place 1 week after
the field centre visit. A follow up visit is expected to
take place 3 years after the baseline examinations.
NIPREGH adheres strictly with ethics of research
involving human subjects as stipulated in the principles
the Declaration of Helsinki
[9]
and has been granted
ethical approval by the Health Research Ethics
Committee of University of Abuja Teaching Hospital.
Data Collection Questionnaire
Standardised questionnaire which had been applied
previously in different Caucasian
[10,11]
and Asian
[12,13]
populations was adapted for use in NIPREGH.
Questions about alcohol and tobacco consumption
include past and present consumption, and type/method
of tobacco use as well as passive smoking. Standard
Table 1 Examination at Office and during Home visits
First
home visit
Office
visit
Second
home visit
History
Socio-demographic X
Family X
Medical X
Lifestyle factors X
Examination
Anthropometry X X
Blood pressure X X X
Arterial phenotype X
Blood biochemistry X X
Malaria parasitology X
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validated questionnaires are adapted to assess other life
style factors, for example, International Physical activity
Questionnaire
[14,15]
, Sheldon Cohen Perceived Stress
Scale (PSS)
[16]
and Berlin Sleep Questionnaire
[17]
for
physical activity, psychosocial stress and sleep disor-
dered breathing, respectively (Table 2).
Anthropometry
With the shoes off, light clothing on, and no cap or
head gear, height and weight were measured with a
standard stadiometer; to the nearest 0.2 cm and
0.1 kg, respectively. Heberden9 s callipers are used to
check skin fold thickness at the triceps, sub-scapular
and right iliac region. The waist circumference is mea-
sured with a non-expansible tape without clothing or
light clothing, in between the lower coastal margin
and the iliac crest with the arm relaxed by the side.
The waist circumference should be done preferable after
an overnight fast but in the event where this is not fea-
sible, the time of the last meal must be documented.
Blood pressure measurement
The observer measures the blood pressure with a
standard mercury sphygmomanometer according to the
2007 guidelines of European Society of Hypertension
(ESH)/European Society of Cardiology (ESC)
[18]
after
the subject has been seated for at least 10 minutes in a
quiet room. The patient9 s chair should provide comfor-
table back support and cuff size is chosen based on arm
circumference according to recommendation. The cuff
must be deflated at approximately 2 mm Hg per second
and systolic and phase V diastolic blood pressure
recorded to the nearest 2 mm Hg. If phase V diastolic
blood pressure cannot be measured, or if phase V dia-
stolic blood pressure is lower than 30 mm Hg, phase
IV diastolic blood pressure must be recorded. Five con-
secutive blood pressure readings are obtained in the sit-
ting position with a 30-60 second interval between
the readings. The results of all blood pressure readings
must be immediately recorded on the study forms.
Maintaining the same conditions as for the examination
with the mercury sphygmomanometer, two blood pres-
sure measurements are carried out by the observer
with a validated
[19]
oscillometric device (Omron 705IT,
OMRON Healthcare Europe BV, Nieuwegein, the
Netherlands). Individual subjects are trained on the
use of the Omron device and are subsequently guided
to measure their blood pressure under the supervision
of the observers immediately after the training.
Subsequently, the participant takes the Omron device
home to measure his/her blood pressure two times in
the morning within one hour of waking up and two
times in the evening just before going to bed for 6 days.
A recording diary with provisions for entry of blood
pressure values immediately after each reading is also
handed over to the subject. A second home visit takes
place by the end of the 6 days of self-monitoring of
home blood pressure during which an observer takes
the blood pressure of the participant home five times
consecutively using the mercury sphygmomanometer.
Quality control for office and home blood
pressure monitoring
The following measures are to improve the quality
of blood pressure measurement. First, the last digit of
the blood pressure value must be even i.e., 0, 2, 4, 6,
or 8 (and not 3, 5, 7, or 9). Digit preferences of the
observers are monitored at 3-monthly intervals through-
out the NIPREGH project. Second, every 3 months, the
observers must pass a test requiring them to read blood
pressures from a video tape featuring a falling mercury
column with Korotkoff sounds (Blood pressure mea-
surements, British Medical Association, London,
England) and the readings must comply within 5 mm
Hg of those of experienced physicians.
[20,21]
Table 2 Interview structure and components
Questionnaire Variable(s)
Socio-demographic characteristics Age, gender, ethnicity, state of origin (of father), Educational and occupational history, marital history.
Family history History of hypertension in first degree relatives
Medical history Self-rated health, past history of hypertension, diabetes, kidney disease and frequency of malaria attacks
Medication use Prescription and non-prescription drugs, use of antimalarial
Alcohol Present and past consumption and type and of alcohol consumed. Reason for stopping
Tobacco Past and current smoking. Type tobacco and method of consumption, second hand smoking
Physical activity[14;15] Leisure, occupation and sport-related place activity
Sleep disordered breathing[17] Presence and severity of snoring, daytime somnelence
Psychosocial factors[16] Perception of stress in daily activities, ability to cope with situations perceived as stressful
Reproductive health Menarche, Previous pregnancies, use of contraceptives, hormonal therapy, previous history of hypertension
or diabetes in pregnancy, premenstrual syndrome[39]
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Intermediate cardiovascular phenotype assess-
ment
A paperless Cardiax device (http://www.rdsm.eu/
cardiax.html) interfaced with a computer is used to
obtain a standard 12-lead ECGs. Using the Cardiax
software, version 3.50.2 (RDSM, Hasselt, Belgium),
the ECG recordings are printed both electronically
and as a hard copy. Voltages and duration of ECG
waves are derived from 16-sec ECGs, while 5-min
recordings are analyzed for the spectral variability of
heart rate in the frequency domain.
Both carotid-femoral pulse wave velocity and pulse
wave analysis are derived by means of radial tonome-
try using the SphygmoCor device. After the partici-
pants had rested in the supine position for 10 to
15 minutes, an 8-second record of the radial waveform
at the dominant arm is obtained by applanation tono-
metry using a high-fidelity SPC-301micromanometer
(Millar Instrument, Inc., Houston, TX, USA) interfaced
with a laptop computer running SphygmoCor software,
version 7.1 (AtCor Medical Pty. Ltd., WestRyde, New
South Wales, Australia). Recordings depicting more
than 5% variability in the systolic or diastolic consecu-
tive waveforms or the amplitude of the pulse wave sig-
nal less than 80 mV are discarded. The pulse wave is
calibrated using the systolic and diastolic blood pres-
sures recorded immediately before the procedure with
the oscillometric OMRON 705IT recorders.
Biochemical examination
For haematological and biochemical examination,
samples are collected using appropriate recipients and
handled according to standard laboratory methods.
Immediate assessment of blood glucose and total cho-
lesterol is done with an Accutrend PlusH device (Roche
Diagnostics GmbH, Germany). Four aliquots (two
each of plasma and serum) are separated and stored
immediately at -20uC. Stored samples are shipped to
the biobank of Studies Coordinating Centre Leuven,
Belgium and stored at -80uC for future analysis
DNA extraction and genotyping
Blood for DNA extraction and genotyping is drawn
in EDTA and stored at -20C. DNA extraction will be
done at Central Laboratory in Milan. NucleoSpin
BloodL Columns (Macherey Nagel) will be used for
DNA purification. The average DNA yield is 20-
30 mg per mL of human blood. Genotyping will be
performed starting from 200 ng DNA following the
Illumina Infinium II protocol that allows interrogation
up to hundreds of thousands polymorphic loci per
sample. Very briefly, DNA is isothermally amplified,
??? ???? ??? ????
???????????????????
Fig. 1 Map of Nigeria showing the state of origin of recruited participants across Nigeria. Inset is the location of Nigeria within the
continent of Africa
NIPREGH: objectives and protocol 363
and then the amplified DNA is enzymatically frag-
mented, precipitated and re-suspended. Re-suspended
samples are hybridized to the array where DNA
anneals to locus specific probes covalently linked to
the array surface. After hybridization, a base extension
step followed by fluorescence staining allows confer-
ing allele specificity to each locus. Fluorescence sig-
nals are detected by the Illumina iScan reader and
analysed with the Illumina GenomeStudio Software
that converts fluorescence to allele and genotype calls.
Notification of and referral for study findings
Study participants and their physicians if requested
by the participants will be notified via a report form
that contains anthropometric records, ECG findings,
blood glucose and cholesterol values. Subjects who
are found to have unfavourable lifestyle factors receive
education on ways of reducing risk associated with
CVDs by physician members of the NIPREGH team.
Any medical condition discovered that should be trea-
ted on an urgent basis will be communicated via phone
to the participant and/ or their physician.
Data management/statistics
Trained technicians code the questionnaire and all
data are keyed in twice using a password protected
computer into a SAS dataset and the paper form stored
as backup in a fireproof cabinet. Data generated by the
computer interfaced instruments are exported and
backed up in an external storage device and are trans-
ferred periodically to Studies Coordinating Centre
Leuven via E mail. Duplicate data sets are compared
with the PROC COMPARE procedure in SAS to
detect input errors. Data coders and SAS programmes
check the internal consistencies of questionnaire
replies. Data derived from Cardiax ECG are exported
in both XML and PDF format while that from the
SphygmoCor device in Excel format and then stored
for subsequent offline analysis. Laboratory specimens
are identified with a code that is made up of the unique
identification number, type of specimen and date of
collection. Aliquot of both plasma and the serum sam-
ples are periodically shipped to Studies Coordinating
Centre Leuven, Belgium for storage in the biobank.
RESULTS
The state of origin of the 160 participants, 58% of
whom are women; spanned across 24 out of 36 states
of Nigeria (Fig. 1) The age distribution as shown in
Fig. 2 typifies the age structure of Nigeria with age
ranging from 18 to 80 years and mean (SD), 39.8
(12.4) years. 66 (41.3%) participants consume signifi-
cant alcohol while 4 (2.5%, all men) smoked cigarette.
43 (26.8%) and 8 (5.0%) were hypertensive and diabetic
respectively. Women were significantly more obese
(P , 0.01) than men, mean (SD) BMI; 27.9 (5.3) vs.
25.7 (4.2) kg/m
2
. Other aspects of the baseline charac-
teristics are shown in Table 3. The office blood pres-
sure averaged 113 mmHg systolic and 73.5 mmHg
diastolic, while the corresponding self-measured home
values were 117.3 mmHg, and 76.0 mmHg, respec-
tively (Table 4).
??
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Fig. 2 Age distribution of recruited participants (hatched
bars) in comparison with the country age distribution (solid
bars) as reported in the 2006 census figures.
Table 3 Baseline clinical characteristics
Characteristic Women Men All
Number of subjects (%) 72(45) 88(160) 160(100)
Smokers 0(0.0) 4(4.5) 4(2.5)
Drinking alcohol 21(29.2) 45(51.1){ 66(41.3)
Diabetes mellitus 5(6.9) 3(3.4) 8(5.0)
Hypertension 21(29.2) 22(25.0) 43(26.8)
Masked hypertension 3(4.2) 6(6.8) 9(5.6)
White-coat hypertension 7(9.7) 6(6.8) 13(8.1)
Mean characteristic(SD)
Age, y 39.3(13.4) 40.3(11.6) 39.8(12.4)
Weight, kg 74.9(15.9) 79.6(14.4) 77.5(15.3)
Height, m 163.7(5.7) 175.8(6.2){ 170.4(8.5)
Body mass index, kg/m2 27.9(5.3) 25.7(4.2){ 26.7(4.8)
Waist circumference, cm 95.5(12.2) 92.9(17.0) 94.0(15.0)
Hip circumference, cm 108.5(10.9) 102.6(11.4){ 105.3(11.5)
Waist-to-hip ratio 0.87(0.06) 0.9(0.1) 0.89(0.09)
Skin fold thickness, mm 17.5(9.0) 15.1(7.8) 16.2(8.4)
Arm circumference, cm 33.5(5.7) 32.5(4.1) 32.9(4.8)
Casual blood glucose, mmol/l 6.2(1.7) 5.8(0.8) 6.0(1.4)
Heart rate, beats per minute 75.9(10.5) 71.9(9.8)* 73.7(10.3)
Comparison between women and men, *P , 0.05, {P , 0.01, {P ,
0.001. Hypertension: either on antihypertensive treatment or office
blood pressure > 140/90mmHg; Diabetes mellitus: either on treatment
or casual blood glucose (measured irrespective of last meal greater than
11.1 mmol/L).
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DISCUSSION
To our knowledge, NIPREGH is the first prospective
population based study on CVD that recruits participants
from diverse ethnic groups in Nigeria. NIPREGH has the
potential to generate important insights into the burden
of risk factors and their contribution to subclinical and
clinical cardiovascular disease in Nigeria, a middle
income country currently undergoing rapid epidemiolo-
gical and demographic transition. This information will
inform future health policies.
Some of the strengths of NIPREGH deserve to be
discussed. The location of the study in Abuja offers
the best opportunity to study the diverse ethnic groups
in Nigeria. Abuja, founded in 1976 as the new Federal
Capital Territory of Nigeria is located at the centre of
the country. Nigerians of different ethnic background
migrate from their ancestral homes to Abuja in search
of rapidly growing employment opportunities. The
population dynamics of Abuja shows that much more
immigration than emigration is the case and this offers
additional opportunity of retention of participants during
follow up. Furthermore, Inhabitants of Federal Housing
Authority Estate, the direct location of the study are
mainly educated workers in government offices with
few of them owning private business. The choice of
such cohort allows, in addition to aforementioned
advantages, the administration of relatively complex
questionnaire which might not be readily understood
by participants of lower educational status.
By enrolment age starting at 18 years, NIPREGH is
poised to investigate the early processes leading to
subclinical and subsequent overt CVDs among black
people. Several longitudinal and observational studies
that compared Blacks and Whites in the Western
countries have reported that CVDs start earlier among
Blacks and run a more aggressive course
[1,22,23]
. The
reason for this difference has remained an unanswered
research question. The information that will be derived
from NIPREGH has the potential to address some of
these questions.
The extensive nature of the measurements in
NIPREGH is intended to contribute to the basic psy-
chosocial and pathophysiological pathways of causation
and progression of CVDs. Assessment of sleep disor-
ders, psychosocial stress and self-home measured blood
pressure is novel in this regard. Hitherto, data generated
among blacks living in Europe and America is extrapo-
lated to African blacks. Such extrapolation does not give
account for differences in natural selection in previous
generation
[24]
, ethnic admixture
[25]
and living environ-
ment and lifestyle
[26]
. Furthermore, interpretation of
these findings is usually complicated by confounding
variables including differential access to healthcare
[27]
and unequal racial representation
[28]
in many large scale
clinical and population studies. These shortcomings are
obviated in NIPREGH as the study population is made
up of Blacks born and living in Africa. The self-mea-
sured home blood pressure data will be useful for setting
diagnostic thresholds as no report of home blood pres-
sure measurement in sub-Saharan Africa is available in
the literature up until now.
The result of the pilot phase of NIPREGH has
demonstrated clearly that the protocol can be implemen-
ted and the objectives achieved. At the moment, we have
had a response rate of 78%, recruited participants of 34
different ethnic groups and from 24 out of the 36 states
that constitute Nigeria (Fig. 1). The age distribution of
the participants mirrors closely that reported in 2006
national census figures (Fig. 2)
[29]
. The data generated
so far are of good quality. A recent check of blood pres-
sure phenotype (the main phenotype of interest) shows
that zero digit preference among observers was 27.1%.
This compares favourably well with the 24% reported
in the well standardised European Project of Gene in
Hypertension (EPOGH) project
[21]
. The prevalence of
hypertension and diabetes (Tables 1 and 2) in the pilot
sample was 26.8 and 5.0% respectively. This falls within
the range of the prevalence rates of between 22.3 to
35.4% for hypertension
[30-33]
; and 2.8 to 5.1%
[33,34]
for
diabetes reported in previous community studies across
different regions of Nigeria
Setting up a population based epidemiological study
as NIPREGH in a resource poor setting as ours has
been fraught with challenges. Lack of funding, poor
research infrastructure, religious and cultural beliefs
Table 4 Baseline haemodynamic characteristics of
office and home examination
Characteristic
Women Men All
N572 N588 N5160
Office blood pressure
Systolic, mm Hg 110.9(16.7) 114.7(13.6) 113.0(15.2)
Diastolic, mm Hg 71.4(12.7) 75.2(12.2) 73.5(12.5)
Home blood pressure
Morning and evening
Systolic, mm Hg 110.8(15.2) 122.3(13.0)* 117.3(15.0)
Diastolic, mm Hg 74.5(10.3) 77.2(8.8) 76.0(9.6)
Morning
Systolic, mm Hg 111.9(15.5) 122.4(13.0)* 117.8(15.5)
Diastolic, mm Hg 75.6(10.1) 78.1(9.4) 77.0(9.7)
Evening
Systolic, mm Hg 109.7(15.4) 121.6(12.3)* 116.5(14.9)
Diastolic, mm Hg 73.2(11.4) 76.5(9.0) 75.1(10.2)
Comparison between women and men, *P , 0.0001
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and unsteady power supply are some of the challenges
we have continued to grapple with. Some innovative
ideas employed during the planning, design and the
implementation of the pilot phase have helped immen-
sely to surmount many of these challenges. The princi-
pal investigator has been receiving training at the
Studies Coordinating Centre, University of Leuven
since 2010. This linkage has not only provided the
needed skills for epidemiological research, it has also
offered invaluable network opportunities within a wider
international research consortium involving investiga-
tors in Asia, Europe and South America. The success
of NIPREGH so far owes largely to the support pro-
vided through these collaborative efforts. The facilities
available within the local environment have also been
maximally utilised. Medical students of College of
Health Sciences, University of Abuja as well as grad-
uate youths undergoing the mandatory one year
National Youth Service Corps Programme are engaged
as volunteers for community mobilisation. We also
benefit from the expertise of research institutions within
Abuja metropolis in terms of sourcing for local con-
sumables necessary for laboratory work. Continuous
dialogue with religious and community leaders has
helped a great deal with community mobilisation.
Furthermore, home visits by observers, engaging parti-
cipants in measurement of their own blood pressure at
home, and health education for subjects identified to
have some modifiable cardiovascular risks all serve as
incentives in line with the principle of beneficence as
stipulated in the Belmont Report
[35]
. These strategies
have further increased trust and acceptability of the
project among the community residents. Our group
successfully concluded the first multinational anti-
hypertensive drug trial in sub-Saharan Africa-Newer
vs Older Anti-hypertensive Agents in African
Hypertensive patients (NOAAH)
[36-38]
. This randomised
clinical trial was carried out in 7 centres (2 of which
were in Nigeria) located within sub-Saharan Africa.
The experience gained in NOAAH trial has also been
very useful in conducting NIPREGH. In conclusion,
NIPREGH is a response to the epidemic of CVDs in
sub-Saharan Africa. The challenges inherent in con-
ducting such a population study in a low resource set-
ting are huge but surmounting them through a creative
epidemiological design reveals the enormous potentials
therein for advancing human knowledge.
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